Moreover, targeting surface ENO1 significantly increased the therapeutic response to radiotherapy and delayed tumor regrowth by increasing antitumoral M1 macrophages and cytotoxic CD8<sup>+</sup> T cells infiltration within TME. Here, ENO1 is linked to neoplasm.